TheraCryf (LSE:TCF) Total Operating Expense: £2.24 Mil (TTM As of Sep. 2025)


What is TheraCryf Total Operating Expense?

TheraCryf LSE:TCF Total Operating Expense is £2.24 Mil as of Sep. 2025. The stock has 3 warning signs investors should review.

TheraCryf's Total Operating Expense for the six months ended in Sep. 2025 was £1.37 Mil. TheraCryf's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2025 was £2.24 Mil.

TheraCryf Total Operating Expense Related Terms

TheraCryf Total Operating Expense Historical Data

* Premium members only.

The historical data trend for TheraCryf's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TheraCryf Total Operating Expense Chart

TheraCryf Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.40 3.19 5.51 3.96 2.12

TheraCryf Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.86 2.10 1.25 0.87 1.37

TheraCryf Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £2.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of £2.24 Mil mean?
TheraCryf (LSE:TCF) has a Total Operating Expense of £2.24 Mil as of Sep. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on TheraCryf and its competitors.
Is TheraCryf's Total Operating Expense too high?
TheraCryf's current Total Operating Expense is £2.24 Mil.
How does TheraCryf's Total Operating Expense compare to VRTX and REGN?
TheraCryf's Total Operating Expense of £2.24 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on TheraCryf and its competitors. TheraCryf's current Total Operating Expense is £2.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TheraCryf stock overvalued right now?
TheraCryf (LSE:TCF) has a current Total Operating Expense of £2.24 Mil. The current Total Operating Expense is £2.24 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For TheraCryf (LSE:TCF), the current Total Operating Expense is £2.24 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TheraCryf Business Description

Address Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG
TheraCryf PLC is a clinical stage therapeutics company developing therapeutic candidates for behavioural brain disorders such as opioid and alcohol addiction, and acute/chronic fatigue. It focuses on data generation to support potential partnerships for its programs with mid-sized and large pharmaceutical companies. The company's pipeline includes Ox-1 - Substance Use Disorders (SUDs) / Anxiety, DAT - Fatigue and Narcolepsy, SFX-01, and SFX-01- Neurodevelopmental Disorders.